Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login
Users Online :1019
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.



 Coming soon

GUEST EDITORIAL
1.  Is hysterectomy needed in ovarian cancer?
ORIGINAL ARTICLE
1.  Gemcitabine and Docetaxel combination in treatment of anthracyclin-pretreated advanced soft tissue sarcoma
2.  Chemosuppressive Effect of Plumbagin on Human Non-Small Lung Cancer Cell Xenotransplanted Zebrafish
3.  Demographic, Clinical, Biochemical, Radiological and Etiological Characteristics of Malignant Pleural Effusions from Eastern India
4.  Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma
5.  Chronic Myeloid Leukemia in Children and Adolescents: A single centre experience from India
6.  Percutaneous vertebroplasty and interventional tumor removal for spinal metastatic tumor without compression
7.  Role of Chemotherapy In the Management of Gestational Trophoblastic Disease : A Prospective Audit.
8.  Mutational Study of Kras in Bladder Cancer in Kashmiri population
9.  Relationship of clinicopathologic characteristic and treatment methods with prognosis of triple-negative breast cancer
10.  Inhibition of Lung Adenocarcinoma Cancer Cells by IGF-IR and KRAS Mutations: A Mutation Analysis With Antisense Oligodeoxynucleotide
11.  Palliative thoracic radiotherapy in advanced lung cancer: A Single institution experience
12.  Mutational Analysis of Erythropoietin Gene and its Enhancer in Anemic Cancer Patients
13.  Effects of Hippo pathway in colorectal cancer
14.  Outcomes in lung cancer: an experience from routine tertiary care setting
15.  Solitary pulmonary nodule evaluation in regions endemic for infectious diseases : Do regional variations impact the effectiveness of FDG PET/CT.
16.  METASTATIC NON-SMALL LUNG CANCER IN SOUTH INDIA: A REGIONAL DEMOGRAPHIC STUDY
17.  Role Of Pneumonectomy For Lung Cancer In Current Scenario: An Indian Perspective
18.  A PROSPECTIVE STUDY OF TELEPHONIC CONTACT AND SUBSEQUENT PHYSICAL FOLLOW UP OF RADICALLY TREATED LUNG CANCER PATIENTS
19.  Comparison studty of Quality of life in advanced lung cancer patients on Tyrosine kinase inhibitor and platinum doublet chemotherapy
20.  Metastasectomy for recurrent or metastatic biliary tract cancers: a single center experience.
21.  EGFR positive lung cancer : The non trial scenario
22.  A meta-analysis:evaluate The safety and efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor monotherapy versus platinum-based doublets chemotherapy in East Asia
23.  Retrospectively Analysis of Icotinib Neoadjuvant Therapy for 63 Cases of Lung Cancer Patients
24.  Epidemiology of gynaecological cancers in Kamrup Urban District Cancer Registry
25.  Clinical profile of non small cell lung carcinoma patients treated in a single unit at a tertiary cancer care centre
26.  ROLE OF CRIZOTINIB IN C-MET POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS – A CASE SERIES
27.  First line therapy outcomes in patients with advanced stage NSCLC treated at Non Government Tertiary care centre in India – experience from a real world practice
28.  Clinical profile and outcomes of patients with stage IV adenocarcinoma of lung – A tertiary cancer centre experience
29.  Anaplastic lymphoma kinase (ALK) immunohistochemistry in lung adenocarcinomas: evaluation of performance of standard manual method using D5F3 antibody
30.  ALK status in lung cancers –an IHC and FISH study from a tertiary cancer centre in India
31.  DUAL MUTATIONS AND COMPLEX MUTATIONS IN METASTATIC NON SMALL CELL LUNG CANCER: A SINGLE INSTITUTION EXPERIENCE FROM SOUTH INDIA.
32.  Gemcitabine and carboplatin in metastatic nonsmall cell lung cancer: Experience from a tertiary cancer centre in South India
33.  The increasing challenge of never smokers with adenocarcinoma lung, need to look beyond tobacco exposure
34.  Study of Gefitinib maintenance in unselected patients with metastatic primary lung adenocarcinoma- Descriptive study.
35.  Lung Cancer -Presentation and Pattern of Care in a Cancer Centre in South India
36.  ACTUAL GAINS IN DOSIMETRY AND TREATMENT DELIVERY EFFICIENCY FROM VOLUMETRIC MODULATED ARC RADIOTHERAPY (VMAT) FOR INOPERABLE, LOCALLY-ADVANCED LUNG CANCER OVER FIVE FIELD FORWARD PLANNED INTENSITY MODULATED RADIOTHERAPY (5-F FORWARD IMRT)
37.  NEWER INSIGHTS INTO ALK POSITIVE NSCLC
38.  The efficacy and safety of preoperative chemotherapy for patients with non-small cell lung cancer: a meta-analysis
39.  Robotic resections in Hepatobiliary oncology – Initial Experience with Xi da Vinci system in India
40.  Induction chemotherapy in locally advanced T4b oral cavity squamous cell cancers: A regional cancer centre experience
41.  Tumor characteristics and metabolic quantification in Carcinoma Breast – An institutional experience
42.  HISTOPATHOLOGICAL ANALYSIS OF MENINGIOMA AND ITS VARIANTS – A STUDY OF 50 CASES.
43.  ORAL HEALTH RELATED QUALITY OF LIFE (OHRQoL) IN PATIENTS TREATED FOR ORAL MALIGNANCY AT KANCHIPURAM DISTRICT; INDIA: A CROSS SECTIONAL STUDY
44.  AN AUDIT AND ANALYSIS OF DIFFERENT CAUSES OF DEFAULTS IN PATIENTS RECEIVING RADIATION FOR HEAD AND NECK CANCERS - A TERTIARY REGIONAL CANCER CENTER EXPERIENCE.
45.  Testicular Seminoma: Are clinical features and Treatment outcomes any different in India?
46.  Composite lymphomas: Experience from a tertiary cancer centre in Kerala, South India
47.  MULTIPLE MYELOMA: EXPERIENCE OF AN INSTITUTE IN LIMITED RESOURCE SETTING
48.  Evaluation of Dose Conformity and Coverage of Target Volume for Intensity Modulated Radiotherapy of Pelvic Cancer Treatment.
49.  Indian consensus statement for treatment of advanced Non-Small Cell Lung Cancer: First line, maintenance and second line
50.  Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer
51.  Comparison of paclitaxel -cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers.
52.  CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (CHART) USING MODERN RADIOTHERAPY TECHNIQUES FOR NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS UNSUITABLE FOR CHEMO-RADIATION
53.  Survival and prognostic factors for Glioblastoma multiformie- Retrospective single institutional study
54.  Stereotactic Body Radiation Therapy for hepatocellular carcinoma, experience from a tertiary cancer care center in India
55.  Retrospective study of efficacy and safety of neoadjuvant Docetaxel, Carboplatin and Trastuzumab (TCH) in HER2 positive locally advanced and oligometastatic breast cancer – An Indian experience
56.  “Comparision of Conventional fractionation (5 Fractions/week) and Altered fractionation (6 Fractions/week) in Stage I and II Squamous cell carcinoma of Oropharynx- An Institutional Study”
57.  Development and validation of a predictive score, for identifying poor ECOG PS (PS 3-4) advanced NSCLC patients who are likely to benefit from tyrosine kinase inhibitors
58.  Rechallenge temozolomide in Glioma : A case series from India
59.  Predicting locoregional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes post mastectomy: Development of a predictive nomogram
60.  Pattern of distant metastasis in molecular subtypes of Carcinoma Breast – An institutional study
61.  A PROSPECTIVE RANDOMIZED TRIAL COMPARING CAPECITABINE BASED CHEMORADIOTHERAPY WITH 5-FU BASED CHEMORADIOTHERAPY IN NEOADJUVANT SETTING IN LOCALLY ADVANCED CARCINOMA RECTUM
62.  Prognostic factors and treatment of patients with advanced Synovial Sarcoma, single center experience
63.  Efficacy and safety of first-line systemic chemotherapy with ECF and DCF regimens in locally advanced inoperable or metastatic gastric or gastro-esophageal junction (GEJ) adenocarcinoma - a prospective phase II study from south India
64.  Impect Of Induction Chemotherapy To Concurrent Chemoirradiation Over Radiotherapy Alone In Advanced Oral Cavity
65.  The comparision of thoracoscopic-laparoscopic esophagectomy and open esophagectomy: a meta-analysis
66.  Effect of tyrosine kinase inhibitors on the glucose levels in diabetic and nondiabetic patients
67.  CERITINIB IN ALK POSITIVE NSCLC AMONG PATIENTS WHO WERE PREVIOUSLY EXPOSED TO CRIZOTINIB: EXPERIENCE FROM THE INDIAN SUBCONTINENT
68.  Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature
69.  : ‘ A Comparative Analysis of Immunohistochemistry (IHC) & Fluorescent in situ Hybridization (FISH) assay to detect ALK status in lung adenocarcinoma cases ; a search for a testing algorithm’
ORIGINAL ARTICLE - ANTI TOBACCO ISSUE
1.  Effect of Radiotherapy on Oral Fungal colonization, its correlation with invasive fungal infections and outcome in patients of head and neck malignancies: need for antifungal prophylaxis?
REVIEW ARTICLE
1.  Mediastinal staging for non-small cell lung cancer revisited. It is being done under aegis of ICON and Lung cancer consortium asia.
2.  Pomalidomide in Multiple Myeloma
3.  Metformin use and survival of lung cancer patients: Meta-analysis Findings
4.  Venous Thromboembolism In Cancer Patients Magnitude Of Problem, Approach And Management A Review Article
5.  Related factors of postoperative gallstone formation after distal gastrectomy: A meta-analysis
6.  Is pulmonary metastatectomy beneficial in head and neck squamous cell carcinoma? A review of literature
LETTER
1.  “Uncommon central nervous system metastasis from primary epithelial ovarian carcinoma”.
2.  Hepatoid adenocarcinoma of the stomach – a rare histology of gastric adenocarcinoma in an adolescent: a case report.
3.  Cysticercosis masquerading as scar site recurrence in a post mastectomy Breast cancer patient
4.  Acute Promyelocytic Leukemia with PLZF-RAR positivity identified at molecular level – A case report
5.  Practical solutions to EGFR-TKI dose modifications in resource constrained settings: thinking outside the (packaging) box
6.  FDG avid Pulmonary mucinous adenocarcinoma presenting with non FDG avid cystic brain lesions of Unknown etiopathology: Brain MRI and FDG PET-CT imaging features and additional value of whole body PET acquisition
7.  letter to the editor
8.  Nivolumab instills hope in a hopeless situation in advanced NSCLC with poor performance status
9.  Sister Mary Josephæs nodule: Two rare cases of inoperable gallbladder cancer
10.  Atypical lung carcinoid -An Unusual Presentation
11.  Chemo port Insertion via Femoral Vein Approach – Rare Indication and Rare Complication
EDITORIAL
1.  Tuberculosis in EGFR mutation Adenocarcinoma lung on Treatment with Gefitinib/ Erlotinib


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow